NCT00254657View on ClinicalTrials.gov

Levetiracetam for Treatment of Pain Associated With Fibromyalgia

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

March 31, 2005

Study Completion Date

April 30, 2005

Conditions
Fibromyalgia
Interventions
DRUG

Levetiracetam

Started with one 500 mg tablet/day and titrated upward as tolerated over 6 weeks by 500 mg/week to a maximum dose of 3000 mg/day.

DRUG

Placebo

Trial Locations (1)

94115

UCSF, San Francisco

Sponsors

Collaborators (1)

UCB Pharma
All Listed Sponsors
collaborator

UCB Pharma

INDUSTRY

lead

University of California, San Francisco

OTHER